{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:41:43Z","timestamp":1791229303035,"version":"4.1.0"},"reference-count":127,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T00:00:00Z","timestamp":1624406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T00:00:00Z","timestamp":1624406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100007514","name":"Universit\u00e0 di Pisa","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007514","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s40266-021-00877-z","type":"journal-article","created":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T02:03:06Z","timestamp":1624413786000},"page":"655-670","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Current Insights into Treating Vertigo in Older Adults"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5261-9129","authenticated-orcid":false,"given":"Augusto Pietro","family":"Casani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2948-6588","authenticated-orcid":false,"given":"Mauro","family":"Gufoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5466-584X","authenticated-orcid":false,"given":"Silvia","family":"Capobianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,23]]},"reference":[{"key":"877_CR1","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/B978-0-444-63437-5.00005-4","volume":"137","author":"HK Neuhauser","year":"2016","unstructured":"Neuhauser HK. The epidemiology of dizziness and vertigo. Handb Clin Neurol. 2016;137:67\u201382. https:\/\/doi.org\/10.1016\/B978-0-444-63437-5.00005-4.","journal-title":"Handb Clin Neurol"},{"key":"877_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.4081\/gc.2017.7160","volume":"3","author":"AP Casani","year":"2017","unstructured":"Casani AP, Navari E. Dizziness and prevention of falls in the elderly. Geriatr Care. 2017;3:75\u20137. https:\/\/doi.org\/10.4081\/gc.2017.7160.","journal-title":"Geriatr Care."},{"key":"877_CR3","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3233\/VES-150564","volume":"25","author":"C Schlick","year":"2016","unstructured":"Schlick C, Schniepp R, Loidl V, et al. Falls and fear of falling in vertigo and balance disorders: a controlled cross-sectional study. J Vestib Res. 2016;25:241\u201351. https:\/\/doi.org\/10.3233\/VES-150564.","journal-title":"J Vestib Res"},{"key":"877_CR4","doi-asserted-by":"crossref","unstructured":"Walther L, Kleeberg J, Rejmanowski G, et al. Falls and fall risk factors. Are they relevant in ENT outpatient medical care? HNO. 2012; May:446, 448\u201356","DOI":"10.1007\/s00106-011-2395-8"},{"key":"877_CR5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3233\/VES-130494","volume":"23","author":"E Soto","year":"2013","unstructured":"Soto E, Vega R, Sese\u00f1a E. Neuropharmacological basis of vestibular system disorder treatment. J Vestib Res. 2013;23:119\u201337. https:\/\/doi.org\/10.3233\/VES-130494.","journal-title":"J Vestib Res"},{"key":"877_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/VES-2009-0343","volume":"19","author":"A Bisdorff","year":"2009","unstructured":"Bisdorff A, Von Brevern M, Lempert T, Newman-Toker DE. Classification of vestibular symptoms: towards an international classification of vestibular disorders. J Vest Res. 2009;19:1\u201313. https:\/\/doi.org\/10.3233\/VES-2009-0343.","journal-title":"J Vest Res."},{"key":"877_CR7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2165\/00023210-200317020-00002","volume":"17","author":"TC Hain","year":"2003","unstructured":"Hain TC, Uddin M. Pharmacological treatment of vertigo. CNS Drugs. 2003;17:85\u2013100. https:\/\/doi.org\/10.2165\/00023210-200317020-00002.","journal-title":"CNS Drugs"},{"key":"877_CR8","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/S0194-5998(00)70187-2","volume":"122","author":"JS Oghalai","year":"2000","unstructured":"Oghalai JS, Manolidis S, Barth JL, et al. Unrecognized benign paroxysmal positional vertigo in elderly patients. Otolaryngol Head Neck Surg. 2000;122:630\u20134.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"877_CR9","doi-asserted-by":"publisher","first-page":"873e","DOI":"10.1097\/MAO.0000000000000391","volume":"35","author":"EG Piker","year":"2014","unstructured":"Piker EG, Jacobson GP. Self-report symptoms differ between younger and older dizzy patients. Otol Neurotol. 2014;35:873e\u20139e. https:\/\/doi.org\/10.1097\/MAO.0000000000000391.","journal-title":"Otol Neurotol"},{"key":"877_CR10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00405-019-05690-4","volume":"277","author":"L Michel","year":"2020","unstructured":"Michel L, Laurent T, Alain T. Rehabilitation of dynamic visual acuity in patients with unilateral vestibular hypofunction: earlier is better. Eur Arch Otorhinolaryngol. 2020;277:103\u201313. https:\/\/doi.org\/10.1007\/s00405-019-05690-4.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"877_CR11","doi-asserted-by":"publisher","first-page":"S104","DOI":"10.4103\/0976-500X.120969","volume":"4","author":"S Chimirri","year":"2013","unstructured":"Chimirri S, Aiello R, Mazzitello C, et al. Vertigo\/dizziness as a Drugs\u2019 adverse reaction. J Pharmacol Pharmacother. 2013;4:S104\u20139.","journal-title":"J Pharmacol Pharmacother"},{"key":"877_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3233\/VES-190655","volume":"29","author":"HA Kim","year":"2019","unstructured":"Kim HA, Bisdorff A, Bronstein AM, et al. Hemodynamic orthostatic dizziness\/vertigo: diagnostic criteria. J Vestib Res. 2019;29:45\u201356. https:\/\/doi.org\/10.3233\/VES-190655.","journal-title":"J Vestib Res"},{"key":"877_CR13","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3233\/VES-190672","volume":"29","author":"Y Agrawal","year":"2019","unstructured":"Agrawal Y, Van de Berg R, Wuyts F, et al. Presbyvestibulopathy: diagnostic criteria consensus document of the classification committee of the B\u00e1r\u00e1ny Society. J Vest Res. 2019;29:161\u201370. https:\/\/doi.org\/10.3233\/VES-190672.","journal-title":"J Vest Res."},{"key":"877_CR14","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1186\/s12877-020-01899-9","volume":"20","author":"V Regauer","year":"2020","unstructured":"Regauer V, Seckler E, M\u00fcller M, Bauer P. Physical therapy interventions for older people with vertigo, dizziness and balance disorders addressing mobility and participation: a systematic review. BMC Geriatr. 2020;20:494. https:\/\/doi.org\/10.1186\/s12877-020-01899-9.","journal-title":"BMC Geriatr"},{"key":"877_CR15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1055\/s-0039-3402739","volume":"40","author":"KA Kerber","year":"2020","unstructured":"Kerber KA. Acute vestibular syndrome. Semin Neurol. 2020;40:59\u201366. https:\/\/doi.org\/10.1055\/s-0039-3402739.","journal-title":"Semin Neurol"},{"key":"877_CR16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/B978-0-444-63437-5.00015-7","volume":"137","author":"M Fetter","year":"2016","unstructured":"Fetter M. Acute unilateral loss of vestibular function. Handb Clin Neurol. 2016;137:219\u201329. https:\/\/doi.org\/10.1016\/B978-0-444-63437-5.00015-7.","journal-title":"Handb Clin Neurol"},{"key":"877_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jemermed.2016.09.016","volume":"52","author":"RD Shih","year":"2017","unstructured":"Shih RD, Walsh B, Eskin B, et al. Diazepam and meclizine are equally effective in the treatment of vertigo: an emergency department randomized double-blind placebo-controlled trial. J Emerg Med. 2017;52:23\u20137. https:\/\/doi.org\/10.1016\/j.jemermed.2016.09.016.","journal-title":"J Emerg Med"},{"key":"877_CR18","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1177\/019459989210600220","volume":"106","author":"FB Horak","year":"1992","unstructured":"Horak FB, Jones-Rycewicz C, Black FO, et al. Effects of vestibular rehabilitation on dizziness and imbalance. Otolaryngol Head Neck Surg. 1992;106:175\u201380.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"877_CR19","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s00415-015-7903-4","volume":"263","author":"M Lacour","year":"2016","unstructured":"Lacour M, Helmchen C, Vidal PP. Vestibular compensation: the neuro-otologist\u2019s best friend. J Neurol. 2016;263:54\u201364. https:\/\/doi.org\/10.1007\/s00415-015-7903-4.","journal-title":"J Neurol"},{"key":"877_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/00019052-200002000-00006","volume":"13","author":"IS Curthoys","year":"2000","unstructured":"Curthoys IS. Vestibular compensation and substitution. Curr Opin Neurol. 2000;13:27\u201330.","journal-title":"Curr Opin Neurol"},{"key":"877_CR21","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/00129492-200205000-00023","volume":"23","author":"CP Pianese","year":"2002","unstructured":"Pianese CP, Hidalgo LOV, Gonz\u00e1lez RH, et al. New approaches to the management of peripheral vertigo: efficacy and safety of two calcium antagonists in a 12-week, multinational, double-blind study. Otol Neurotol. 2002;23:357\u201363. https:\/\/doi.org\/10.1097\/00129492-200205000-00023.","journal-title":"Otol Neurotol"},{"key":"877_CR22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.2165\/00044011-200525060-00003","volume":"25","author":"Z Cirek","year":"2005","unstructured":"Cirek Z, Schwarz M, Baumann W, Novotny M. Efficacy and tolerability of a fixed combination of cinnarizine and dimenhydrinate versus betahistine in the treatment of otogenic vertigo: a double-blind randomised clinical study. Clin Drug Investig. 2005;25:377\u201389. https:\/\/doi.org\/10.2165\/00044011-200525060-00003.","journal-title":"Clin Drug Investig"},{"key":"877_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2165\/00044011-200828020-00003","volume":"28","author":"A Hahn","year":"2008","unstructured":"Hahn A, Sejna I, Stefflova B, et al. A fixed combination of cinnarizine\/dimenhydrinate for the treatment of patients with acute vertigo due to vestibular disorders: a randomized, reference-controlled clinical study. Clin Drug Investig. 2008;28:89\u201399. https:\/\/doi.org\/10.2165\/00044011-200828020-00003.","journal-title":"Clin Drug Investig"},{"key":"877_CR24","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2165\/11632410-000000000-00000","volume":"32","author":"A-W Scholtz","year":"2012","unstructured":"Scholtz A-W, Steindl R, Burchardi N, et al. Comparison of the therapeutic efficacy of a fixed low-dose combination of cinnarizine and dimenhydrinate with betahistine in vestibular neuritis: a randomized, double-blind, non-inferiority study. Clin Drug Investig. 2012;32:387\u201399. https:\/\/doi.org\/10.2165\/11632410-000000000-00000.","journal-title":"Clin Drug Investig"},{"key":"877_CR25","first-page":"429","volume":"3","author":"M Lacour","year":"2007","unstructured":"Lacour M, van de Heyning PH, Novotny M, Tighilet B. Betahistine in the treatment of M\u00e9ni\u00e8re\u2019s disease. Neuropsychiatr Dis Treat. 2007;3:429\u201340.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"877_CR26","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3389\/fneur.2018.00431","volume":"9","author":"B Tighilet","year":"2018","unstructured":"Tighilet B, L\u00e9onard J, Watabe I, et al. Betahistine treatment in a cat model of vestibular pathology: pharmacokinetic and pharmacodynamic approaches. Front Neurol. 2018;9:431. https:\/\/doi.org\/10.3389\/fneur.2018.00431.","journal-title":"Front Neurol"},{"key":"877_CR27","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/cns.12451","volume":"22","author":"L Yu","year":"2016","unstructured":"Yu L, Zhang X-Y, Cao S-L, et al. Na(+)\u2013Ca(2+) exchanger, leak K(+) channel and hyperpolarization-activated cyclic nucleotide-gated channel comediate the histamine-induced excitation on rat inferior vestibular nucleus neurons. CNS Neurosci Ther. 2016;22:184\u201393. https:\/\/doi.org\/10.1111\/cns.12451.","journal-title":"CNS Neurosci Ther"},{"key":"877_CR28","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1471-2202-5-32","volume":"5","author":"AF Lozada","year":"2004","unstructured":"Lozada AF, Aarnisalo AA, Karlstedt K, et al. Plasticity of histamine H3receptor expression and binding in the vestibular nuclei after labyrinthectomy in rat. BMC Neurosci. 2004;5:32. https:\/\/doi.org\/10.1186\/1471-2202-5-32.","journal-title":"BMC Neurosci"},{"key":"877_CR29","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/s0014-2999(02)01795-8","volume":"446","author":"B Tighilet","year":"2002","unstructured":"Tighilet B, Trottier S, Mourre C, et al. Betahistine dihydrochloride interaction with the histaminergic system in the cat: neurochemical and molecular mechanisms. Eur J Pharmacol. 2002;446:63\u201373. https:\/\/doi.org\/10.1016\/s0014-2999(02)01795-8.","journal-title":"Eur J Pharmacol"},{"key":"877_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039086","volume":"7","author":"F Ihler","year":"2012","unstructured":"Ihler F, Bertlich M, Sharaf K, et al. Betahistine exerts a dose-dependent effect on cochlear stria vascularis blood flow in guinea pigs in vivo. PLoS ONE. 2012;7: e39086. https:\/\/doi.org\/10.1371\/journal.pone.0039086.","journal-title":"PLoS ONE"},{"key":"877_CR31","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1159\/000368293","volume":"20","author":"M Bertlich","year":"2015","unstructured":"Bertlich M, Ihler F, Freytag S, et al. Histaminergic H3-heteroreceptors as a potential mediator of betahistine-induced increase in cochlear blood flow. Audiol Neurootol. 2015;20:283\u201393. https:\/\/doi.org\/10.1159\/000368293.","journal-title":"Audiol Neurootol"},{"key":"877_CR32","first-page":"24","volume":"21","author":"L Botta","year":"2001","unstructured":"Botta L, Mira E, Valli S, et al. Effects of betahistine and of its metabolites on vestibular sensory organs. Acta Otorhinolaryngol Ital. 2001;21:24\u201330.","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"877_CR33","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s00405-013-2596-8","volume":"271","author":"JJP Nauta","year":"2014","unstructured":"Nauta JJP. Meta-analysis of clinical studies with betahistine in M\u00e9ni\u00e8re\u2019s disease and vestibular vertigo. Eur Arch Otorhinolaryngol. 2014;271:887\u201397. https:\/\/doi.org\/10.1007\/s00405-013-2596-8.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"877_CR34","first-page":"14","volume":"16","author":"H Benecke","year":"2010","unstructured":"Benecke H, P\u00e9rez-Garrigues H, Bin Sidek D, et al. Effects of betahistine on patient-reported outcomes in routine practice in patients with vestibular vertigo and appraisal of tolerability: experience in the OSVaLD study. Int Tinnitus J. 2010;16:14\u201324.","journal-title":"Int Tinnitus J"},{"key":"877_CR35","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3389\/fneur.2019.00147","volume":"10","author":"M Lindner","year":"2019","unstructured":"Lindner M, Gosewisch A, Eilles E, et al. Ginkgo biloba extract EGb 761 improves vestibular compensation and modulates cerebral vestibular networks in the rat. Front Neurol. 2019;10:147. https:\/\/doi.org\/10.3389\/fneur.2019.00147.","journal-title":"Front Neurol"},{"key":"877_CR36","doi-asserted-by":"publisher","first-page":"CD010696","DOI":"10.1002\/14651858.CD010696.pub2","volume":"6","author":"L Murdin","year":"2016","unstructured":"Murdin L, Hussain K, Schilder AG. Betahistine for symptoms of vertigo. Cochrane Database Syst Rev. 2016;6:CD010696. https:\/\/doi.org\/10.1002\/14651858.CD010696.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"877_CR37","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1056\/NEJMoa033280","volume":"351","author":"M Strupp","year":"2004","unstructured":"Strupp M, Zingler VC, Arbusow V, et al. Methylprednisolone, valacyclovir, or the combination for vestibular neuritis. N Engl J Med. 2004;351:354\u201361. https:\/\/doi.org\/10.1056\/NEJMoa033280.","journal-title":"N Engl J Med"},{"key":"877_CR38","doi-asserted-by":"publisher","DOI":"10.1177\/0194599820982910","author":"KJ Leong","year":"2021","unstructured":"Leong KJ, Lau T, Stewart V, Canetti E. Systematic review and meta-analysis: effectiveness of corticosteroids in treating adults with acute vestibular neuritis. Otolaryngol Head Neck Surg. 2021. https:\/\/doi.org\/10.1177\/0194599820982910.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"877_CR39","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1007\/s00415-015-7918-x","volume":"262","author":"A Batuecas-Caletrio","year":"2015","unstructured":"Batuecas-Caletrio A, Yanez R, Sanchez C, et al. Glucorcorticoids improve acute dizziness symptoms following acute unilateral vestibulopathy. J Neurol. 2015;262:2578\u201382. https:\/\/doi.org\/10.1007\/s00415-015-7918-x.","journal-title":"J Neurol"},{"key":"877_CR40","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1097\/MAO.0000000000002106","volume":"40","author":"J Sj\u00f6gren","year":"2019","unstructured":"Sj\u00f6gren J, Magnusson M, Tjernstr\u00f6m F, Karlberg M. Steroids for acute vestibular neuronitis\u2014the earlier the treatment, the better the outcome? Otol Neurotol. 2019;40:372\u20134. https:\/\/doi.org\/10.1097\/MAO.0000000000002106.","journal-title":"Otol Neurotol"},{"key":"877_CR41","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-3801-8","volume-title":"Vertigo: its multisensory syndromes","author":"T Brandt","year":"2003","unstructured":"Brandt T. Vertigo: its multisensory syndromes. 2nd ed. London: Springer; 2003.","edition":"2"},{"key":"877_CR42","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3233\/VES-2004-14105","volume":"14","author":"R J\u00f6nsson","year":"2004","unstructured":"J\u00f6nsson R, Sixt E, Landahl S, Rosenhall U. Prevalence of dizziness and vertigo in an urban elderly population. J Vestib Res. 2004;14:47\u201352.","journal-title":"J Vestib Res"},{"key":"877_CR43","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1097\/MOO.0b013e32833ce5a6","volume":"18","author":"JM Furman","year":"2010","unstructured":"Furman JM, Raz Y, Whitney SL. Geriatric vestibulopathy assessment and management. Curr Opin Otolaryngol Head Neck Surg. 2010;18:386\u201391. https:\/\/doi.org\/10.1097\/MOO.0b013e32833ce5a6.","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"877_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjorl.2017.06.003","author":"KF Ribeiro","year":"2017","unstructured":"Ribeiro KF, Oliveira BS, Freitas RV, et al. Effectiveness of Otolith repositioning maneuvers and vestibular rehabilitation exercises in elderly people with benign paroxysmal positional vertigo: a systematic review. Braz J Otorhinolaryngol. 2017. https:\/\/doi.org\/10.1016\/j.bjorl.2017.06.003.","journal-title":"Braz J Otorhinolaryngol"},{"key":"877_CR45","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/jgs.13926","volume":"64","author":"K Parham","year":"2016","unstructured":"Parham K, Kuchel GA. A geriatric perspective on benign paroxysmal positional vertigo. J Am Geriatr Soc. 2016;64:378\u201385. https:\/\/doi.org\/10.1111\/jgs.13926.","journal-title":"J Am Geriatr Soc"},{"key":"877_CR46","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1177\/0194599816689667","volume":"156","author":"N Bhattacharyya","year":"2017","unstructured":"Bhattacharyya N, Gubbels SP, Schwartz SR, et al. Clinical practice guideline: benign paroxysmal positional vertigo (Update). Otolaryngol Head Neck Surg. 2017;156:S1\u201347. https:\/\/doi.org\/10.1177\/0194599816689667.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"877_CR47","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3988\/jcn.2008.4.3.107","volume":"4","author":"JI Seok","year":"2008","unstructured":"Seok JI, Lee HM, Yoo JH, Lee DK. Residual dizziness after successful repositioning treatment in patients with benign paroxysmal positional vertigo. J Clin Neurol. 2008;4:107\u201310. https:\/\/doi.org\/10.3988\/jcn.2008.4.3.107.","journal-title":"J Clin Neurol"},{"key":"877_CR48","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1007\/s00405-018-4980-x","volume":"275","author":"C Vaduva","year":"2018","unstructured":"Vaduva C, Est\u00e9ban-S\u00e1nchez J, Sanz-Fern\u00e1ndez R, Mart\u00edn-Sanz E. Prevalence and management of post-BPPV residual symptoms. Eur Arch Otorhinolaryngol. 2018;275:1429\u201337. https:\/\/doi.org\/10.1007\/s00405-018-4980-x.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"877_CR49","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3109\/00016489.2011.637179","volume":"132","author":"HJ Jung","year":"2012","unstructured":"Jung HJ, Koo J-W, Kim CS, et al. Anxiolytics reduce residual dizziness after successful canalith repositioning maneuvers in benign paroxysmal positional vertigo. Acta Otolaryngol. 2012;132:277\u201384. https:\/\/doi.org\/10.3109\/00016489.2011.637179.","journal-title":"Acta Otolaryngol"},{"key":"877_CR50","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1002\/lary.24741","volume":"124","author":"M-B Kim","year":"2014","unstructured":"Kim M-B, Lee HS, Ban JH. Vestibular suppressants after canalith repositioning in benign paroxysmal positional vertigo. Laryngoscope. 2014;124:2400\u20133. https:\/\/doi.org\/10.1002\/lary.24741.","journal-title":"Laryngoscope"},{"key":"877_CR51","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1177\/0194599811419093","volume":"146","author":"EA Guneri","year":"2012","unstructured":"Guneri EA, Kustutan O. The effects of betahistine in addition to epley maneuver in posterior canal benign paroxysmal positional vertigo. Otolaryngol Neck Surg. 2012;146:104\u20138. https:\/\/doi.org\/10.1177\/0194599811419093.","journal-title":"Otolaryngol Neck Surg."},{"key":"877_CR52","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1080\/00016480500280140","volume":"126","author":"T Brandt","year":"2006","unstructured":"Brandt T, Huppert D, Hecht J, et al. Benign paroxysmal positioning vertigo: a long-term follow-up (6\u201317 years) of 125 patients. Acta Otolaryngol. 2006;126:160\u20133. https:\/\/doi.org\/10.1080\/00016480500280140.","journal-title":"Acta Otolaryngol"},{"key":"877_CR53","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/MAO.0b013e3182487f78","volume":"3","author":"P P\u00e9rez","year":"2012","unstructured":"P\u00e9rez P, Franco V, Cuesta P, et al. Recurrence of benign paroxysmal positional vertigo. Otol Neurotol. 2012;3:437\u201343. https:\/\/doi.org\/10.1097\/MAO.0b013e3182487f78.","journal-title":"Otol Neurotol"},{"key":"877_CR54","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s40520-017-0763-2","volume":"30","author":"S-C Yeo","year":"2018","unstructured":"Yeo S-C, Ahn S-K, Lee HJ, et al. Idiopathic benign paroxysmal positional vertigo in the elderly: a long-term follow-up study. Aging Clin Exp Res. 2018;30:153\u20139. https:\/\/doi.org\/10.1007\/s40520-017-0763-2.","journal-title":"Aging Clin Exp Res"},{"key":"877_CR55","doi-asserted-by":"publisher","DOI":"10.1177\/0145561320943362","author":"S Li","year":"2020","unstructured":"Li S, Wang Z, Liu Y, et al. Risk factors for the recurrence of benign paroxysmal positional vertigo: a systematic review and meta-analysis. Ear Nose Throat J. 2020. https:\/\/doi.org\/10.1177\/0145561320943362.","journal-title":"Ear Nose Throat J"},{"key":"877_CR56","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1007\/s00405-018-5146-6","volume":"275","author":"MA AlGarni","year":"2018","unstructured":"AlGarni MA, Mirza AA, Althobaiti AA, et al. Association of benign paroxysmal positional vertigo with vitamin D deficiency: a systematic review and meta-analysis. Eur Arch Otorhinolaryngol. 2018;275:2705\u201311. https:\/\/doi.org\/10.1007\/s00405-018-5146-6.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"877_CR57","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1055\/s-0029-1241043","volume":"29","author":"HK Neuhauser","year":"2009","unstructured":"Neuhauser HK, Lempert T. Vertigo: epidemiologic aspects. Semin Neurol. 2009;29:473\u201381. https:\/\/doi.org\/10.1055\/s-0029-1241043.","journal-title":"Semin Neurol"},{"key":"877_CR58","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1136\/jnnp.2006.100420","volume":"78","author":"M von Brevern","year":"2007","unstructured":"von Brevern M, Radtke A, Lezius F, et al. Epidemiology of benign paroxysmal positional vertigo: a population based study. J Neurol Neurosurg Psychiatry. 2007;78:710\u20135. https:\/\/doi.org\/10.1136\/jnnp.2006.100420.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"877_CR59","doi-asserted-by":"publisher","first-page":"e1117","DOI":"10.1212\/WNL.0000000000010343","volume":"95","author":"S-H Jeong","year":"2020","unstructured":"Jeong S-H, Kim J-S, Kim H-J, et al. Prevention of benign paroxysmal positional vertigo with vitamin D supplementation: a randomized trial. Neurology. 2020;95:e1117\u201325. https:\/\/doi.org\/10.1212\/WNL.0000000000010343.","journal-title":"Neurology"},{"key":"877_CR60","doi-asserted-by":"publisher","DOI":"10.1439\/0392-100X-847","author":"R Teggi","year":"2016","unstructured":"Teggi R, Manfrin M, Balzanelli C, et al. Point prevalence of vertigo and dizziness in a sample of 2672 subjects and correlation with headaches. Acta Otorhinolaryngol. 2016. https:\/\/doi.org\/10.1439\/0392-100X-847.","journal-title":"Acta Otorhinolaryngol"},{"key":"877_CR61","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.otc.2010.05.009","volume":"43","author":"D Vibert","year":"2010","unstructured":"Vibert D, Caversaccio M, H\u00e4usler R. Meniere\u2019s disease in the elderly. Otolaryngol Clin N Am. 2010;43:1041\u20136. https:\/\/doi.org\/10.1016\/j.otc.2010.05.009.","journal-title":"Otolaryngol Clin N Am"},{"key":"877_CR62","doi-asserted-by":"publisher","first-page":"CD012173","DOI":"10.1002\/14651858.CD012173.pub2","volume":"12","author":"K Hussain","year":"2018","unstructured":"Hussain K, Murdin L, Schilder AG. Restriction of salt, caffeine and alcohol intake for the treatment of M\u00e9ni\u00e8re\u2019s disease or syndrome. Cochrane Database Syst Rev. 2018;12:CD012173. https:\/\/doi.org\/10.1002\/14651858.CD012173.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"877_CR63","doi-asserted-by":"publisher","first-page":"5359208","DOI":"10.1155\/2018\/5359208","volume":"2018","author":"AP Casani","year":"2018","unstructured":"Casani AP, Navari E, Guidetti G, Lacour M. Good clinical approach: Delphi consensus for the use of betahistine in Meni\u00e8re\u2019s disease. Int J Otolaryngol. 2018;2018:5359208. https:\/\/doi.org\/10.1155\/2018\/5359208.","journal-title":"Int J Otolaryngol."},{"key":"877_CR64","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h6816","volume":"352","author":"C Adrion","year":"2016","unstructured":"Adrion C, Fischer CS, Wagner J, et al. Efficacy and safety of betahistine treatment in patients with Meniere\u2019s disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial). BMJ. 2016;352: h6816. https:\/\/doi.org\/10.1136\/bmj.h6816.","journal-title":"BMJ"},{"key":"877_CR65","doi-asserted-by":"publisher","first-page":"CD001873","DOI":"10.1002\/14651858.CD001873","volume":"2001","author":"AL James","year":"2001","unstructured":"James AL, Burton MJ. Betahistine for Meni\u00e8re\u2019s disease or syndrome. Cochrane database Syst Rev. 2001;2001:CD001873. https:\/\/doi.org\/10.1002\/14651858.CD001873.","journal-title":"Cochrane database Syst Rev"},{"key":"877_CR66","first-page":"208","volume":"26","author":"C Della Pepa","year":"2006","unstructured":"Della Pepa C, Guidetti G, Eandi M. Betahistine in the treatment of vertiginous syndromes: a meta-analysis. Acta Otorhinolaryngol Ital. 2006;26:208\u201315.","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"877_CR67","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s00405-011-1647-2","volume":"268","author":"F Lezius","year":"2011","unstructured":"Lezius F, Adrion C, Mansmann U, et al. High-dosage betahistine dihydrochloride between 288 and 480 mg\/day in patients with severe Meni\u00e8re\u2019s disease: a case series. Eur Arch Otorhinolaryngol. 2011;268:1237\u201340. https:\/\/doi.org\/10.1007\/s00405-011-1647-2.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"877_CR68","first-page":"97","volume-title":"Meni\u00e8re\u2019s disease: evidence and outcomes","author":"J Shen","year":"2010","unstructured":"Shen J, Ruckenstein M. Medical treatment of Meni\u00e8re\u2019s Disease. In: Meni\u00e8re\u2019s disease: evidence and outcomes. San Diego: Plural Publishing; 2010. p. 97\u2013104."},{"key":"877_CR69","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1002\/lary.28040","volume":"129","author":"S Stern Shavit","year":"2019","unstructured":"Stern Shavit S, Lalwani AK. Are diuretics useful in the treatment of meniere disease? Laryngoscope. 2019;129:2206\u20137. https:\/\/doi.org\/10.1002\/lary.28040.","journal-title":"Laryngoscope"},{"key":"877_CR70","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003599.pub2","author":"A Burgess","year":"2006","unstructured":"Burgess A, Kundu S. Diuretics for M\u00e9ni\u00e8re\u2019s disease or syndrome. Cochrane Database Syst Rev. 2006. https:\/\/doi.org\/10.1002\/14651858.CD003599.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"877_CR71","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.otc.2010.05.003","volume":"43","author":"SD Rauch","year":"2010","unstructured":"Rauch SD. Clinical hints and precipitating factors in patients suffering from Meniere\u2019s disease. Otolaryngol Clin N Am. 2010;43:1011\u20137. https:\/\/doi.org\/10.1016\/j.otc.2010.05.003.","journal-title":"Otolaryngol Clin N Am"},{"issue":"5","key":"877_CR72","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1177\/0194599816630733","volume":"154","author":"MG Crowson","year":"2016","unstructured":"Crowson MG, Patki A, Tucci DL. A systematic review of diuretics in the medical management of M\u00e9ni\u00e8re\u2019s disease. Otolaryngol Head Neck Surg. 2016;154(5):824\u201334.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"877_CR73","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1177\/0194599820909438","volume":"162","author":"GJ Basura","year":"2020","unstructured":"Basura GJ, Adams ME, Monfared A, et al. Clinical practice guideline: M\u00e9ni\u00e8re\u2019s disease. Otolaryngol Head Neck Surg. 2020;162:S1\u201355. https:\/\/doi.org\/10.1177\/0194599820909438.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"877_CR74","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3174\/ajnr.A4462","volume":"37","author":"AR Sepahdari","year":"2016","unstructured":"Sepahdari AR, Vorasubin N, Ishiyama G, Ishiyama A. Endolymphatic hydrops reversal following acetazolamide therapy: demonstration with delayed intravenous contrast-enhanced 3D-FLAIR MRI. Am J Neuroradiol. 2016;37:151\u20134. https:\/\/doi.org\/10.3174\/ajnr.A4462.","journal-title":"Am J Neuroradiol"},{"key":"877_CR75","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/MAO.0000000000002467","volume":"41","author":"MH Froehlich","year":"2020","unstructured":"Froehlich MH, Lambert PR. The physiologic role of corticosteroids in Meni\u00e8re\u2019s disease: an update on glucocorticoid-mediated pathophysiology and corticosteroid inner ear distribution. Otol Neurotol. 2020;41:271\u20136. https:\/\/doi.org\/10.1097\/MAO.0000000000002467.","journal-title":"Otol Neurotol"},{"key":"877_CR76","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1152\/physiolgenomics.00006.2005","volume":"24","author":"SR Pondugula","year":"2006","unstructured":"Pondugula SR, Raveendran NN, Ergonul Z, et al. Glucocorticoid regulation of genes in the amiloride-sensitive sodium transport pathway by semicircular canal duct epithelium of neonatal rat. Physiol Genom. 2006;24:114\u201323. https:\/\/doi.org\/10.1152\/physiolgenomics.00006.2005.","journal-title":"Physiol Genom"},{"key":"877_CR77","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1007\/s00424-014-1629-5","volume":"467","author":"J Nevoux","year":"2015","unstructured":"Nevoux J, Viengchareun S, Lema I, et al. Glucocorticoids stimulate endolymphatic water reabsorption in inner ear through aquaporin 3 regulation. Pflugers Arch. 2015;467:1931\u201343. https:\/\/doi.org\/10.1007\/s00424-014-1629-5.","journal-title":"Pflugers Arch"},{"key":"877_CR78","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1080\/00016480802078119","volume":"129","author":"H Otake","year":"2009","unstructured":"Otake H, Yamamoto H, Teranishi M, et al. Cochlear blood flow during occlusion and reperfusion of the anterior inferior cerebellar artery\u2014effect of topical application of dexamethasone to the round window. Acta Otolaryngol. 2009;129:127\u201331. https:\/\/doi.org\/10.1080\/00016480802078119.","journal-title":"Acta Otolaryngol"},{"key":"877_CR79","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1097\/01.mao.0000185057.81962.51","volume":"26","author":"E Morales-Luckie","year":"2005","unstructured":"Morales-Luckie E, Cornejo-Suarez A, Zaragoza-Contreras MA, Gonzalez-Perez O. Oral administration of prednisone to control refractory vertigo in M\u00e9ni\u00e8re\u2019s disease: a pilot study. Otol Neurotol. 2005;26:1022\u20136. https:\/\/doi.org\/10.1097\/01.mao.0000185057.81962.51.","journal-title":"Otol Neurotol"},{"key":"877_CR80","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1097\/MAO.0b013e31826dba83","volume":"33","author":"LM Fisher","year":"2012","unstructured":"Fisher LM, Derebery MJ, Friedman RA. Oral steroid treatment for hearing improvement in M\u00e9ni\u00e8re\u2019s disease and endolymphatic hydrops. Otol Neurotol. 2012;33:1685\u201391. https:\/\/doi.org\/10.1097\/MAO.0b013e31826dba83.","journal-title":"Otol Neurotol"},{"issue":"10061","key":"877_CR81","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1016\/S0140-6736(16)31461-1","volume":"388","author":"M Patel","year":"2016","unstructured":"Patel M, Agarwal K, Arshad Q, et al. Intratympanic methylprednisolone versus gentamicin in patients with unilateral M\u00e9ni\u00e8re\u2019s disease: a randomised, double-blind, comparative effectiveness trial. Lancet. 2016;388(10061):2753\u201362. https:\/\/doi.org\/10.1016\/S0140-6736(16)31461-1.","journal-title":"Lancet"},{"key":"877_CR82","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.joto.2017.06.002","volume":"3","author":"M Patel","year":"2017","unstructured":"Patel M. Intratympanic corticosteroids in M\u00e9ni\u00e8re\u2019s disease: a mini-review. J Otol. 2017;3:117\u201324. https:\/\/doi.org\/10.1016\/j.joto.2017.06.002.","journal-title":"J Otol"},{"key":"877_CR83","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/coa.13350","volume":"44","author":"Z Cao","year":"2019","unstructured":"Cao Z, Yue F, Huang W, Rajenderkumar D, Zhao F. Different medications for the treatment of M\u00e9ni\u00e8re\u2019s disease by intratympanic injection: a systematic review and network meta-analysis. Clin Otolaryngol. 2019;44:619\u201327. https:\/\/doi.org\/10.1111\/coa.13350.","journal-title":"Clin Otolaryngol"},{"key":"877_CR84","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008514.pub2","author":"JS Phillips","year":"2011","unstructured":"Phillips JS, Westerberg B. Intratympanic steroids for M\u00e9ni\u00e8re\u2019s disease or syndrome. Cochrane Database Syst Rev. 2011. https:\/\/doi.org\/10.1002\/14651858.CD008514.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"877_CR85","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1097\/MAO.0000000000002255","volume":"40","author":"L Devantier","year":"2019","unstructured":"Devantier L, Djurhuus BD, Hougaard DD, et al. Intratympanic steroid for Meni\u00e8re\u2019s disease: a systematic review. Otol Neurotol. 2019;40:806\u201312. https:\/\/doi.org\/10.1097\/MAO.0000000000002255.","journal-title":"Otol Neurotol"},{"key":"877_CR86","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008234.pub2","author":"B Pullens","year":"2011","unstructured":"Pullens B, van Benthem PP. Intratympanic gentamicin for M\u00e9ni\u00e8re\u2019s disease or syndrome. Cochrane Database Syst Rev. 2011. https:\/\/doi.org\/10.1002\/14651858.CD008234.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"877_CR87","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/lary.27392","volume":"129","author":"JG Naples","year":"2019","unstructured":"Naples JG, Henry L, Brant JA, et al. Intratympanic therapies in M\u00e9ni\u00e8re disease: evaluation of outcomes and early vertigo control. Laryngoscope. 2019;129:216\u201321. https:\/\/doi.org\/10.1002\/lary.27392.","journal-title":"Laryngoscope"},{"key":"877_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0237523","volume":"15","author":"N Ahmadzai","year":"2020","unstructured":"Ahmadzai N, Cheng W, Kilty S, et al. Pharmacologic and surgical therapies for patients with Meniere\u2019s disease: a systematic review and network meta-analysis. PLoS ONE. 2020;15:1\u201328. https:\/\/doi.org\/10.1371\/journal.pone.0237523.","journal-title":"PLoS ONE"},{"key":"877_CR89","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1177\/0194599811429432","volume":"146","author":"AP Casani","year":"2012","unstructured":"Casani AP, Piaggi P, Cerchiai N, et al. Intratympanic treatment of intractable unilateral Meniere disease: gentamicin or dexamethasone? A randomized controlled trial. Otolaryngol Neck. 2012;146:430\u20137. https:\/\/doi.org\/10.1177\/0194599811429432.","journal-title":"Otolaryngol Neck."},{"key":"877_CR90","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-10011-5","author":"M Jiang","year":"2020","unstructured":"Jiang M, Zhang Z, Zhao C. What is the efficacy of gentamicin on the incidence of vertigo attacks and hearing in patients with Meniere\u2019s disease compared with steroids? A meta-analysis. J Neurol. 2020. https:\/\/doi.org\/10.1007\/s00415-020-10011-5.","journal-title":"J Neurol"},{"key":"877_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MAO.0000000000002451","volume":"41","author":"F Yaz","year":"2020","unstructured":"Yaz F, Ziylan F, Smeeing DPJ, Thomeer HGXM. Intratympanic treatment in Meni\u00e8re\u2019s disease, efficacy of aminoglycosides versus corticosteroids in comparison studies: a systematic review. Otol Neurotol. 2020;41:1\u201310. https:\/\/doi.org\/10.1097\/MAO.0000000000002451.","journal-title":"Otol Neurotol"},{"key":"877_CR92","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1080\/14656566.2020.1775812","volume":"21","author":"JM Espinosa-Sanchez","year":"2020","unstructured":"Espinosa-Sanchez JM, Lopez-Escamez JA. The pharmacological management of vertigo in Meniere disease. Expert Opin Pharmacother. 2020;21:1753\u201363. https:\/\/doi.org\/10.1080\/14656566.2020.1775812.","journal-title":"Expert Opin Pharmacother"},{"key":"877_CR93","first-page":"62","volume":"34","author":"P Pagnini","year":"2014","unstructured":"Pagnini P, Vannucchi P, Giannoni B, Pecci R. Epigone migraine vertigo (EMV): a late migraine equivalent. Acta Otorhinolaryngol Ital. 2014;34:62\u201370.","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"877_CR94","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/lary.28546","volume":"131","author":"YJ Byun","year":"2020","unstructured":"Byun YJ, Levy DA, Nguyen SA, et al. Treatment of vestibular migraine: a systematic review and meta-analysis. Laryngoscope. 2020;131:186\u201394. https:\/\/doi.org\/10.1002\/lary.28546.","journal-title":"Laryngoscope"},{"key":"877_CR95","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.otc.2011.01.014","volume":"44","author":"OA Shoair","year":"2011","unstructured":"Shoair OA, Nyandege AN, Slattum PW. Medication-related dizziness in the older adult. Otolaryngol Clin N Am. 2011;44:455\u201371. https:\/\/doi.org\/10.1016\/j.otc.2011.01.014.","journal-title":"Otolaryngol Clin N Am"},{"key":"877_CR96","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.1007\/s00405-013-2786-4","volume":"271","author":"A Lepcha","year":"2014","unstructured":"Lepcha A, Amalanathan S, Augustine AM, et al. Flunarizine in the prophylaxis of migrainous vertigo: a randomized controlled trial. Eur Arch Otorhinolaryngol. 2014;271:2931\u20136. https:\/\/doi.org\/10.1007\/s00405-013-2786-4.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"877_CR97","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s00228-017-2247-x","volume":"73","author":"K-M Jhang","year":"2017","unstructured":"Jhang K-M, Huang J-Y, Nfor ON, et al. Extrapyramidal symptoms after exposure to calcium channel blocker-flunarizine or cinnarizine. Eur J Clin Pharmacol. 2017;73:911\u20136. https:\/\/doi.org\/10.1007\/s00228-017-2247-x.","journal-title":"Eur J Clin Pharmacol"},{"key":"877_CR98","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1046\/j.1468-2982.1990.1001017.x","volume":"10","author":"V Centonze","year":"1990","unstructured":"Centonze V, Magrone D, Vino M, et al. Flunarizine in migraine prophylaxis: efficacy and tolerability of 5 mg and 10 mg dose levels. Cephalalgia. 1990;10:17\u201324. https:\/\/doi.org\/10.1046\/j.1468-2982.1990.1001017.x.","journal-title":"Cephalalgia"},{"key":"877_CR99","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/j.1552-4604.1988.tb03183.x","volume":"28","author":"F Benvenuti","year":"1988","unstructured":"Benvenuti F, Baroni A, Bandinelli S, et al. Flunarizine-induced parkinsonism in the elderly. J Clin Pharmacol. 1988;28:600\u20138. https:\/\/doi.org\/10.1002\/j.1552-4604.1988.tb03183.x.","journal-title":"J Clin Pharmacol"},{"key":"877_CR100","first-page":"697","volume":"38","author":"VE Ziegler","year":"1977","unstructured":"Ziegler VE, Biggs JT. Electrocardiographic findings in patients undergoing amitriptyline treatment. Dis Nerv Syst. 1977;38:697\u20139.","journal-title":"Dis Nerv Syst"},{"key":"877_CR101","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.1468-2982.2008.01571.x","volume":"28","author":"WM Mulleners","year":"2008","unstructured":"Mulleners WM, Chronicle EP. Anticonvulsants in migraine prophylaxis: a Cochrane review. Cephalalgia. 2008;28:585\u201397. https:\/\/doi.org\/10.1111\/j.1468-2982.2008.01571.x.","journal-title":"Cephalalgia"},{"key":"877_CR102","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3389\/fneur.2017.00524","volume":"8","author":"F Liu","year":"2017","unstructured":"Liu F, Ma T, Che X, et al. The efficacy of venlafaxine, flunarizine, and valproic acid in the prophylaxis of vestibular migraine. Front Neurol. 2017;8:524. https:\/\/doi.org\/10.3389\/fneur.2017.00524.","journal-title":"Front Neurol"},{"key":"877_CR103","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/s0092-8674(00)81373-2","volume":"87","author":"RA Ophoff","year":"1996","unstructured":"Ophoff RA, Terwindt GM, Vergouwe MN, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell. 1996;87:543\u201352. https:\/\/doi.org\/10.1016\/s0092-8674(00)81373-2.","journal-title":"Cell"},{"key":"877_CR104","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1526-4610.2005.05077_3.x","volume":"45","author":"R De Simone","year":"2005","unstructured":"De Simone R, Marano E, Di Stasio E, et al. Acetazolamide efficacy and tolerability in migraine with aura: a pilot study. Headache. 2005;45:385\u20136. https:\/\/doi.org\/10.1111\/j.1526-4610.2005.05077_3.x.","journal-title":"Headache"},{"key":"877_CR105","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1007\/s00405-015-3874-4","volume":"273","author":"N \u00c7elebisoy","year":"2016","unstructured":"\u00c7elebisoy N, G\u00f6k\u00e7ay F, Karahan C, et al. Acetazolamide in vestibular migraine prophylaxis: a retrospective study. Eur Arch Otorhinolaryngol. 2016;273:2947\u201351. https:\/\/doi.org\/10.1007\/s00405-015-3874-4.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"877_CR106","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.3390\/ijerph18041503","volume":"18","author":"L Grazzi","year":"2021","unstructured":"Grazzi L, Toppo C, Damico D, et al. Non-pharmacological approaches to headaches: non-invasive neuromodulation, nutraceuticals, and behavioral approaches. Int J Environ Res Public Health. 2021;18:1503. https:\/\/doi.org\/10.3390\/ijerph18041503.","journal-title":"Int J Environ Res Public Health"},{"key":"877_CR107","doi-asserted-by":"publisher","first-page":"e1715","DOI":"10.1212\/WNL.0000000000008388","volume":"93","author":"SC Beh","year":"2019","unstructured":"Beh SC, Friedman DI. Acute vestibular migraine treatment with noninvasive vagus nerve stimulation. Neurology. 2019;93:e1715-1719.","journal-title":"Neurology"},{"key":"877_CR108","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1177\/0333102419833076","volume":"39","author":"DJHA Henssen","year":"2019","unstructured":"Henssen DJHA, Derks B, van Doorn M, et al. Vagus nerve stimulation for primary headache disorders: an anatomical review to explain a clinical phenomenon. Cephalalgia. 2019;39:1180\u201394.","journal-title":"Cephalalgia"},{"key":"877_CR109","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/j.1527-3466.2006.00214.x","volume":"24","author":"DA Lauver","year":"2006","unstructured":"Lauver DA, Lucchesi BR. Sulodexide: a renewed interest in this glycosaminoglycan. Cardiovasc Drug Rev. 2006;24:214\u201326. https:\/\/doi.org\/10.1111\/j.1527-3466.2006.00214.x.","journal-title":"Cardiovasc Drug Rev"},{"key":"877_CR110","doi-asserted-by":"publisher","DOI":"10.3233\/ch-201043","author":"SH Sohn","year":"2020","unstructured":"Sohn SH, Kim TS, Kim JW, Yoo SM, Jo WM. Anti-thrombotic and anti-inflammatory activity of sulodexide compared to aspirin in the rat model. Clin Hemorheol Microcirc. 2020. https:\/\/doi.org\/10.3233\/ch-201043.","journal-title":"Clin Hemorheol Microcirc"},{"key":"877_CR111","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1177\/1076029609338711","volume":"15","author":"C Adiguzel","year":"2009","unstructured":"Adiguzel C, Iqbal O, Hoppensteadt D, et al. Comparative anticoagulant and platelet modulatory effects of enoxaparin and sulodexide. Clin Appl Thromb. 2009;15:501\u201311. https:\/\/doi.org\/10.1177\/1076029609338711.","journal-title":"Clin Appl Thromb"},{"key":"877_CR112","doi-asserted-by":"publisher","first-page":"205873841877383","DOI":"10.1177\/2058738418773833","volume":"32","author":"G Neri","year":"2018","unstructured":"Neri G, Marcelli V, Califano L. Assessment of the effect of mesoglycan in the treatment of audiovestibular disorders of vascular origin. Int J Immunopathol Pharmacol. 2018;32:2058738418773833. https:\/\/doi.org\/10.1177\/2058738418773833.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"877_CR113","first-page":"169","volume":"27","author":"D Canova","year":"2012","unstructured":"Canova D, Roatta S, Micieli G, Bosone D. Cerebral oxygenation and haemodynamic effects induced by nimodipine in healthy subjects. Funct Neurol. 2012;27:169\u201376.","journal-title":"Funct Neurol"},{"key":"877_CR114","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1161\/01.STR.0000155686.73908.3e","volume":"36","author":"L Pantoni","year":"2005","unstructured":"Pantoni L, del Ser T, Soglian AG, et al. Efficacy and safety of nimodipine in subcortical vascular dementia: a randomized placebo-controlled trial. Stroke. 2005;36:619\u201324. https:\/\/doi.org\/10.1161\/01.STR.0000155686.73908.3e.","journal-title":"Stroke"},{"key":"877_CR115","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/0167-4943(92)90030-8","volume":"14","author":"H Eicher","year":"1992","unstructured":"Eicher H, Hilgert D, Zeeh J, et al. Pharmacokinetics of nimodipine in multimorbid elderly patients with chronic brain failure. Arch Gerontol Geriatr. 1992;14:309\u201319. https:\/\/doi.org\/10.1016\/0167-4943(92)90030-8.","journal-title":"Arch Gerontol Geriatr"},{"key":"877_CR116","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3389\/fneur.2017.00241","volume":"8","author":"N Cerchiai","year":"2017","unstructured":"Cerchiai N, Mancuso M, Navari E, Giannini N, Casani AP. Aging with cerebral small vessel disease and dizziness: the importance of undiagnosed peripheral vestibular disorders. Front Neurol. 2017;8:241. https:\/\/doi.org\/10.3389\/fneur.2017.00241.","journal-title":"Front Neurol"},{"key":"877_CR117","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1212\/01.wnl.0000305959.46197.e6","volume":"70","author":"H Baezner","year":"2008","unstructured":"Baezner H, Blahak C, Poggesi A, et al. Association of gait and balance disorders with age-related white matter changes: the LADIS study. Neurology. 2008;70:935\u201342. https:\/\/doi.org\/10.1212\/01.wnl.0000305959.46197.e6.","journal-title":"Neurology"},{"key":"877_CR118","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/bpa.12219","volume":"25","author":"SB Wharton","year":"2015","unstructured":"Wharton SB, Simpson JE, Brayne C, Ince PG. Age-associated white matter lesions: the MRC cognitive function and ageing study. Brain Pathol. 2015;25:35\u201343. https:\/\/doi.org\/10.1111\/bpa.12219.","journal-title":"Brain Pathol"},{"key":"877_CR119","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.jns.2015.09.006","volume":"358","author":"H Ahmad","year":"2015","unstructured":"Ahmad H, Cerchiai N, Mancuso M, et al. Are white matter abnormalities associated with \u201cunexplained dizziness\u201d? J Neurol Sci. 2015;358:428\u201331. https:\/\/doi.org\/10.1016\/j.jns.2015.09.006.","journal-title":"J Neurol Sci"},{"issue":"3","key":"877_CR120","doi-asserted-by":"publisher","first-page":"160","DOI":"10.2174\/1566524018666180720165055","volume":"18","author":"L Ulivi","year":"2018","unstructured":"Ulivi L, Maccarrone M, Giannini N, et al. Oxidative stress in cerebral small vessel disease dizziness patients, basally and after polyphenol compound supplementation. Curr Mol Med. 2018;18(3):160\u20135. https:\/\/doi.org\/10.2174\/1566524018666180720165055.","journal-title":"Curr Mol Med"},{"key":"877_CR121","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/ijs.12466","volume":"10","author":"PM Bath","year":"2015","unstructured":"Bath PM, Wardlaw JM. Pharmacological treatment and prevention of cerebral small vessel disease: a review of potential interventions. Int J Stroke. 2015;10:469\u201378. https:\/\/doi.org\/10.1111\/ijs.12466.","journal-title":"Int J Stroke"},{"key":"877_CR122","first-page":"2786","volume":"04","author":"P Gamba","year":"2016","unstructured":"Gamba P, Pavia M. White matter lesions and vascular vertigo: clinical correlation and findings on cranial magnetic resonance imaging. Eur Rev Med Pharmacol Sci. 2016;04:2786\u201391.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"877_CR123","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1001\/archotol.128.5.554","volume":"128","author":"JP Staab","year":"2002","unstructured":"Staab JP, Ruckenstein MJ, Solomon D, Shepard NT. Serotonin reuptake inhibitors for dizziness with psychiatric symptoms. Arch Otolaryngol Head Neck Surg. 2002;128:554\u201360. https:\/\/doi.org\/10.1001\/archotol.128.5.554.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"877_CR124","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/B978-0-444-63437-5.00013-3","volume":"137","author":"SL Whitney","year":"2016","unstructured":"Whitney SL, Alghwiri AA, Alghadir A. An overview of vestibular rehabilitation. Handb Clin Neurol. 2016;137:187\u2013205. https:\/\/doi.org\/10.1016\/B978-0-444-63437-5.00013-3.","journal-title":"Handb Clin Neurol"},{"key":"877_CR125","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1097\/00005537-200409000-00025","volume":"114","author":"JP Staab","year":"2004","unstructured":"Staab JP, Ruckenstein MJ, Amsterdam JD. A prospective trial of sertraline for chronic subjective dizziness. Laryngoscope. 2004;114:1637\u201341. https:\/\/doi.org\/10.1097\/00005537-200409000-00025.","journal-title":"Laryngoscope"},{"key":"877_CR126","doi-asserted-by":"publisher","first-page":"898","DOI":"10.3389\/fgene.2019.00898","volume":"10","author":"Z Ungvari","year":"2019","unstructured":"Ungvari Z, Tarantini S, Yabluchanskiy A, Csiszar A. Potential adverse cardiovascular effects of treatment with fluoxetine and other selective serotonin reuptake inhibitors (SSRIs) in patients with geriatric depression: implications for atherogenesis and cerebromicrovascular dysregulation. Front Genet. 2019;10:898. https:\/\/doi.org\/10.3389\/fgene.2019.00898.","journal-title":"Front Genet"},{"key":"877_CR127","volume-title":"Vestibular rehabilitation","author":"S Herdman","year":"2014","unstructured":"Herdman S, Clendaniel R. Vestibular rehabilitation. 4th ed. F A Davis Co; 2014.","edition":"4"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-021-00877-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-021-00877-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-021-00877-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T06:35:24Z","timestamp":1672554924000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-021-00877-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,23]]},"references-count":127,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["877"],"URL":"https:\/\/doi.org\/10.1007\/s40266-021-00877-z","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,23]]},"assertion":[{"value":"5 June 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Open access funding provided by Universit\u00e0 di Pisa within the CRUI-CARE Agreement.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors contributed to the first draft of the manuscript. APC revised the manuscript for intellectual content and approved the final version.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 contribution"}}]}}